This week: Jessica Smith is joined by James, Belle and Albion VC's Molly Gilmartin.
[01:50] SVB fuelled high-risk, high-reward tech firms. Now health start-ups feel bereft
[10:00] Why do so many biotechs face being kicked off the Nasdaq?
[15:15] How UK healthtechs can get a head start on their US expansion
[28:05] Why investors should pay close attention to the UK’s healthtech sector in 2023
✍️ Apply to be a guest at this form
📖 Learn more about the SomX team at somx.health
🖇 Connect with Jessica on LinkedIn
🖇 Connect with James on LinkedIn
🖇 Connect with Belle on LinkedIn
🖇 Connect with Molly on LinkedIn
